- Poster presentation
- Open Access
In vitro evaluation of the combination between some antibiotics and essential oils of clove and rosemary against Pseudomonas aeruginosa
© El Hosseiny and El-Shenawy; licensee BioMed Central Ltd. 2015
Published: 16 June 2015
Emergence of resistance to multiple antimicrobial agents threatens public health at a global scale. One of the most clinically significant multidrug resistant pathogens is Pseudomonas aeruginosa.
The association of antibiotics and plant extracts against resistant pathogens is one of the promising choices for the treatment of infectious diseases.
This work addresses the antibiotic enhancing effect of two essential oils against Pseudomonas aeruginosa. Clove and rosemary essential oils were hydrodistilled from the buds of Syzygiumaromaticum and leaves of and Rosmarinusofficinalis respectively. The chemical composition of the extracted essential oils was identified using gas chromatography coupled mass spectrospcopy analysis. Disc diffusion assay was used to investigate the antibacterial activity of clove and rosemary essential oils against Pseudomonas aeruginosa (ATCC 9027). Furthermore, the antibiotic enhancement capacity of these oils was evaluated in combination with some antipseudomonal drugs comprising ceftazidime, imipenem, aztreonam and ciprofloxacin.
Results revealed that clove essential oil exhibited higher activity towards the test bacterium than rosemary oil. Meanwhile, the antipseudomonal activities of all the tested antibiotics were enhanced in the range of 8-50% when combined with clove oil and 12-33.3% in case of rosemary oil. The antibacterial activity displayed by both essential oils, alone and in association with the antibiotics, is probably related to the major components identified in both oils, comprising eugenol (80.03%) in clove and eucalyptol (29.3%) in rosemary.
Clove and rosemary essential oils are potential candidate antimicrobial natural products that could enhance the activity of conventional antibiotics.
Disclosure of interest
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.